PCN91 The Cost-Effectiveness of Trastuzumab Over the Product Life Cycle in Portugal- A Dynamic and Societal Perspective
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.2131
https://www.valueinhealthjournal.com/article/S1098-3015(12)03845-4/fulltext
Section Title :
Cancer
Section Order :
780
First Page :
A425
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03845-4&doi=10.1016/j.jval.2012.08.2131